APA (7th ed.) Citation

J, v. D., C, P., BBM, S., N, M., N, v. D., G, M., . . . MS, v. d. H. (2024). Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. Nature medicine, 30(1), 304. https://doi.org/10.1038/s41591-023-02500-7

Chicago Style (17th ed.) Citation

J, van Dorp, et al. "Author Correction: High- or Low-dose Preoperative Ipilimumab Plus Nivolumab in Stage III Urothelial Cancer: The Phase 1B NABUCCO Trial." Nature Medicine 30, no. 1 (2024): 304. https://doi.org/10.1038/s41591-023-02500-7.

MLA (9th ed.) Citation

J, van Dorp, et al. "Author Correction: High- or Low-dose Preoperative Ipilimumab Plus Nivolumab in Stage III Urothelial Cancer: The Phase 1B NABUCCO Trial." Nature Medicine, vol. 30, no. 1, 2024, p. 304, https://doi.org/10.1038/s41591-023-02500-7.